Related Experiment Videos

Coagulation screening tests in high risk neonates: a prospective cohort study

B K Schmidt1, P Vegh, M Andrew

  • 1Department of Pediatrics and Pathology, McMaster University, Hamilton, Ontario, Canada.

Insights

Early thrombocytopenia in high-risk newborns predicts coagulation abnormalities better than other factors. This finding aids in identifying neonates needing closer monitoring for bleeding risks.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatrics

Background:

  • Neonates, especially those at high risk, can present with coagulation abnormalities.
  • Identifying reliable predictors of these abnormalities is crucial for timely intervention.

Purpose of the Study:

  • To evaluate early thrombocytopenia as a predictor of abnormal coagulation screening tests in high-risk neonates.
  • To compare the predictive value of early thrombocytopenia against other common risk factors.

Main Methods:

  • Prospective cohort study of 170 high-risk neonates.
  • Coagulation screening tests performed within 36 hours of birth.
  • Analysis of early thrombocytopenia, very low birth weight, fetal growth retardation, and Apgar scores as predictors.

Main Results:

  • Forty-seven infants (27.6%) had abnormal coagulation screening tests.
  • Early thrombocytopenia was a significant predictor of prolonged prothrombin times and hypofibrinogenemia.
  • Very low birth weight, fetal growth retardation, and poor Apgar scores were less predictive.

Conclusions:

  • Early thrombocytopenia is a valuable early indicator of coagulation dysfunction in high-risk neonates.
  • This finding can guide clinical practice in monitoring and managing at-risk newborns.
  • Further research may explore targeted interventions based on early thrombocytopenia detection.

Related Concept Videos